EP1844158A4 - Biomarker for inflammatory bowel disease - Google Patents

Biomarker for inflammatory bowel disease

Info

Publication number
EP1844158A4
EP1844158A4 EP05853365A EP05853365A EP1844158A4 EP 1844158 A4 EP1844158 A4 EP 1844158A4 EP 05853365 A EP05853365 A EP 05853365A EP 05853365 A EP05853365 A EP 05853365A EP 1844158 A4 EP1844158 A4 EP 1844158A4
Authority
EP
European Patent Office
Prior art keywords
biomarker
inflammatory bowel
bowel disease
disease
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05853365A
Other languages
German (de)
French (fr)
Other versions
EP1844158A2 (en
Inventor
Chakravarti Shukti
Feng Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of EP1844158A2 publication Critical patent/EP1844158A2/en
Publication of EP1844158A4 publication Critical patent/EP1844158A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
EP05853365A 2004-12-06 2005-12-06 Biomarker for inflammatory bowel disease Withdrawn EP1844158A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63366204P 2004-12-06 2004-12-06
PCT/US2005/044423 WO2006063133A2 (en) 2004-12-06 2005-12-06 Biomarker for inflammatory bowel disease

Publications (2)

Publication Number Publication Date
EP1844158A2 EP1844158A2 (en) 2007-10-17
EP1844158A4 true EP1844158A4 (en) 2010-09-08

Family

ID=36578568

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05853365A Withdrawn EP1844158A4 (en) 2004-12-06 2005-12-06 Biomarker for inflammatory bowel disease

Country Status (2)

Country Link
EP (1) EP1844158A4 (en)
WO (1) WO2006063133A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2643364C (en) * 2006-03-09 2017-06-06 Salix Pharmaceuticals, Inc. Rifaximin anti-rectal dysfunction preparation
WO2008048986A2 (en) * 2006-10-17 2008-04-24 Children's Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
WO2008079406A2 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Gene expression markers for inflammatory bowel disease
EP2148943B1 (en) * 2007-04-30 2016-10-05 Janssen Biotech, Inc. Methods for assessing and treating ulcerative colitis and related disorders using a 19 gene panel
EP2160475A4 (en) * 2007-05-22 2011-02-09 Centocor Ortho Biotech Inc Markers and methods for assessing and treating crohn's disease and related disorders
US20090155788A1 (en) * 2007-05-22 2009-06-18 Abbas Alexander R Gene expression markers for inflammatory bowel disease
US8663927B2 (en) 2007-09-10 2014-03-04 University Of Kentucky Research Foundation Systems and methods for diagnosis and monitoring of bacteria-related conditions
US9040051B2 (en) * 2007-10-02 2015-05-26 Universitaet Zu Koeln Marker genes for regulatory T cells from human blood
KR20110015409A (en) * 2007-11-29 2011-02-15 제넨테크, 인크. Gene expression markers for inflammatory bowel disease
EP2379752B1 (en) 2009-01-19 2015-09-30 Biomérieux S.A. Methods for determining the susceptibility of a subject to contract a nosocomial infection and for establishing a prognose of evolution of septic syndrome
EP2584049A3 (en) * 2009-07-20 2013-08-28 Genentech, Inc. Gene expression markers for Crohn's disease
WO2011127351A1 (en) * 2010-04-09 2011-10-13 Exagen Diagnostics, Inc. Biomarkers for ulcerative colitis and crohn's disease
CN112941150A (en) * 2021-03-25 2021-06-11 安徽医科大学 Method for screening activity index of ulcerative colitis disease

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000014283A2 (en) * 1998-09-04 2000-03-16 Washington University Gene markers for chronic mucosal injury
US6150096A (en) * 1997-09-26 2000-11-21 Universite De Sherbrooke Molecular markers for the diagnosis of human diseases including Crohn's disease
WO2002059367A2 (en) * 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
WO2002077651A1 (en) * 2001-03-27 2002-10-03 Centre Hospitalier Regional Universitaire De Lille Method for diagnosing chronic intestinal inflammatory diseases
US6632617B1 (en) * 1997-05-13 2003-10-14 Incyte Corporation Tumor-associated antigen
WO2004001073A1 (en) * 2002-06-25 2003-12-31 Index Pharmaceuticals Ab Method and kit for the diagnosis of ulcerative colitis
WO2004058042A2 (en) * 2002-12-30 2004-07-15 Yeda Research And Development Co. Ltd. Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
WO2004065577A2 (en) * 2003-01-14 2004-08-05 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the nf-kb pathway

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774769B2 (en) * 1993-04-26 1998-07-09 賢治 寒川 Adrenomedullin

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632617B1 (en) * 1997-05-13 2003-10-14 Incyte Corporation Tumor-associated antigen
US6150096A (en) * 1997-09-26 2000-11-21 Universite De Sherbrooke Molecular markers for the diagnosis of human diseases including Crohn's disease
WO2000014283A2 (en) * 1998-09-04 2000-03-16 Washington University Gene markers for chronic mucosal injury
WO2002059367A2 (en) * 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
WO2002077651A1 (en) * 2001-03-27 2002-10-03 Centre Hospitalier Regional Universitaire De Lille Method for diagnosing chronic intestinal inflammatory diseases
WO2004001073A1 (en) * 2002-06-25 2003-12-31 Index Pharmaceuticals Ab Method and kit for the diagnosis of ulcerative colitis
WO2004058042A2 (en) * 2002-12-30 2004-07-15 Yeda Research And Development Co. Ltd. Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
WO2004065577A2 (en) * 2003-01-14 2004-08-05 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the nf-kb pathway

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HINSON J P ET AL: "Adrenomedullin, a multifunctional regulatory peptide.", ENDOCRINE REVIEWS, vol. 21, no. 2, April 2000 (2000-04-01), pages 138 - 167, XP002590796, ISSN: 0163-769X *

Also Published As

Publication number Publication date
WO2006063133A3 (en) 2009-04-02
EP1844158A2 (en) 2007-10-17
WO2006063133A2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
EP1844158A4 (en) Biomarker for inflammatory bowel disease
EP2089712A4 (en) Autoimmune disease biomarkers
EP1806581A4 (en) Disease diagnosing system
IL233432A0 (en) Gene expression markers for inflammatory bowel disease
EP1924190A4 (en) Anoscope
EP1907747A4 (en) Mid-seal for expandable connections
EP1815872A4 (en) Composition for amyloid-associated disease diagnosis
GB0702117D0 (en) Early Entry
EP1891893A4 (en) Disease judging supporting system
IL189611A0 (en) Treatment of inflammatory bowel disease
EP1806145A4 (en) Remedy for inflammatory diseases
EP1952138A4 (en) Method for detecting an inflammatory disease or cancer
GB0618127D0 (en) Biomarker
AU304411S (en) Bidet
EP2044957A4 (en) Treatment agent for inflammatory bowel disease
GB0511302D0 (en) Biomarkers
EP2034305A4 (en) Method for determination of inflammatory bowel disease
GB2410799B (en) Fluid-gauging probes
IL215527A0 (en) Improved immunoassay methods
ZA200703666B (en) Biomarker for heart failure
EP1941874A4 (en) Colonic delivery-type therapeutic agent for inflammatory bowel disease
EP1667677A4 (en) Composition for treating inflammatory bowel disease
GB0521360D0 (en) Biomarker
IL218580A (en) Methods for diagnosing an inflammatory disease
AU306014S (en) Bowl

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090402

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 487/00 20060101ALI20090608BHEP

Ipc: A61K 38/00 20060101ALI20090608BHEP

Ipc: A01N 37/18 20060101ALI20090608BHEP

Ipc: C07K 16/00 20060101ALI20090608BHEP

Ipc: C12M 1/34 20060101ALI20090608BHEP

Ipc: G01N 33/53 20060101ALI20090608BHEP

Ipc: C12P 19/34 20060101ALI20090608BHEP

Ipc: C12Q 1/68 20060101AFI20090608BHEP

17P Request for examination filed

Effective date: 20091002

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20100810

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110308